The nation of Zimbabwe has rejected a substantial American healthcare agreement worth 367 million US dollars (272 million pounds) over five years because of Washington's insistence on confidential biological samples.
The decision came to light after a government memo dated December was leaked, revealing that President Emmerson Mnangagwa felt the agreement was "lopsided".
A government spokesperson later explained that the US was seeking genetic material for scientific study and profit while refused to guarantee the benefits from future medical innovations.
"We will now turn to the challenging and unfortunate process of scaling back our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had provided over $1.9bn for health programmes to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has called for further dialogue to secure a agreement suitable to all parties so the country's vital HIV treatment initiative can continue.
Wider Context
This development follows a similar situation in neighbouring Kenya, where a high court blocked a related health funding agreement following concerns were raised about the safety of citizens' health data.
Since resuming office last year, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
USAID had administered aid for the US government, but Trump stated its spending was "wasteful" and his administration was pursuing direct bilateral deals to enhance openness and accountability.
As per reports, Sixteen nations in Africa have to date agreed to similar health pacts, representing more than $18.3bn in new funding.
Specifics of the Declined Deal
The funds for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this cooperation would have delivered immense benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently on antiretroviral therapy via US-supported initiatives," Tremont commented.
However, government spokesperson Nick Mangwana said the proposed deal was "unfair".
"Our nation was requested to provide its biological resources and data over an extended period, with no equivalent guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," he stated.
"Effectively, our country would supply the basic resources for medical research with no assurance that the end products would be available to our people if a future health crisis arise."
National Interest and International Frameworks
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting systems already set up via the global health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing system designed to deal with future global health emergencies.
"This framework is designed to guarantee that when a country contributes its information, the resulting advantages – including medicines and cures – are shared equitably, not monopolised exclusively by those with the resources to create them."
The government's concerns over the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We encourage further dialogue with our American counterparts on how subsequent collaboration could be structured in a manner that respects the sovereignty and interests of both nations."
Health Experts Response
Medical experts expressed it understood the government's concerns, but urged that negotiations must proceed given that much of the nation's HIV programmes relied on external financing.
"If technical issues arise, such as those involving information security or implementation frameworks, these can frequently be addressed through detailed discussion and negotiated safeguards," the group added.
The situation emphasises the continuing challenges between accepting vital international aid and protecting a country's data in an ever more interconnected world.